Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Quality Measures Used to Assess Care, Improve Outcomes in Children, Adults with Rheumatic Diseases

Mary Beth Nierengarten  |  Issue: March 2017  |  March 20, 2017

“PROMIS measures may be good instruments to assess patient reported outcomes in both clinical and research settings for rheumatoid arthritis patients,” said Ms. Wohlfahrt, adding that “further research is needed to determine minimally clinically important differences in these measures for RA patients.”

In another presentation on the use of PROMIS measures in rheumatology, Shanthini Kasturi, MD, a rheumatologist at the Hospital for Special Surgery, New York, presented data from a study that assessed the validity and reliability of PROMIS Global 10 for measuring global physical and mental health in adult patients with systemic lupus erythematosus (SLE).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In the study, 204 adults with SLE were recruited from an SLE Center of Excellence to participate in the study. The study cohort was racially, ethnically and socioeconomically diverse, with most patients identifying themselves as nonwhite and over one-quarter identifying themselves as Hispanic or Latino. Over one-third of the patients were covered by Medicaid. All patients completed the PROMIS Global 10, select PROMIS CATs, as well as the SF-36 and LupusQoL-US measures. Kasturi and colleagues then compared the PROMIS Global 10 scores with those obtained from PROMIS CATs and legacy instruments.

According to Dr. Kasturi, the study is the first to show that collecting PROMIS Global 10 information from a large and diverse group of SLE patients is feasible and that the test is valid and reliable when compared with other legacy SLE patient-reported outcome measures.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“This study is an important first step in demonstrating the potential of the PROMIS Global 10 for the routine measurement of patient-centered outcomes in clinical rheumatology,” said Dr. Kasturi, adding that more studies are needed to evaluate the responsiveness of this test to changes in SLE disease activity as well as to its validity for use in other rheumatic diseases.


Mary Beth Nierengarten is a writer, editor and journalist with over 25 years of medical communications experience.

Miss Any of These Important Sessions?

If you missed any of these important sessions, find them on SessionSelect.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsPediatric ConditionsQuality Assurance/Improvement Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)patient carePediatricPractice ManagementQualityRheumatic Diseaserheumatologistrheumatology

Related Articles

    An Overview of Pediatric, Noninfectious Uveitis

    October 18, 2018

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    Is It Time to Replace the HAQ?

    July 12, 2011

    The PROMIS initiative uses item response theory to improve assessment of patient-reported health and wellbeing

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    What Adult Rheumatologists Need to Know about Juvenile Arthritis

    May 1, 2013

    How to recognize distinctions between pediatric and adult arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences